Does FEMARA Cause Malignant neoplasm progression? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Malignant neoplasm progression have been filed in association with FEMARA. This represents 17.8% of all adverse event reports for FEMARA.
16
Reports of Malignant neoplasm progression with FEMARA
17.8%
of all FEMARA reports
5
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From FEMARA?
Of the 16 reports, 5 (31.3%) resulted in death, 2 (12.5%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FEMARA. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does FEMARA Cause?
Breast cancer metastatic (9)
Fatigue (7)
Nausea (7)
Breast cancer recurrent (6)
Diarrhoea (6)
Disease progression (6)
Arthralgia (5)
Bone pain (5)
Breast cancer (5)
Headache (5)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)